Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1314-1315

  Conti, D J ^a   Isenberg, A ^a   Shen, G K ^a   Hahn, A ^a   Singh, T P ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; AZATHIOPRINE; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GANCICLOVIR; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0031832244     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00256-5     Document Type: Conference Paper

References (12)

1. Rubin RH, Tolkoff-Rubin NE: Antimicrob Agents Chemother 37:619, 1993
2. Rubin RH, Tolkoff-Rubin NE: Transplant Proc 23:2068, 1991
3. Martin M: Transplant Sci 2:83, 1992
4. Snydman DR: Transplant Rev 4:59, 1990
5. Cheeseman SH, Rubin RH, Stewart JA, et al: N Engl J Med 300:1345, 1979
6. Ho M, Suwansirikul S, Dowling JN, et al: N Engl J Med 293:1109, 1975
7. Conti DJ, Freed BM, Lempert N: Arch Surg 129:443, 1994
8. Conti DJ, Shen G, Singh TP, et al: Transplant Proc 29:804, 1997
9. Sollinger HW: Transplantation 60:225, 1995
10. Tricontinental Mycophenolate Renal Transplant Study Group: Transplantation 61:1029, 1996
11. Weir MR, Henry ML, Blackmore M, et al: Transplantation 45:111, 1988
12. Snydman DR, Werner BG, Heinze-Lacey B, et al: N Engl J Med 317:1049, 1987